- Home
- AMPH vs PCT Comparison
AMPH vs PCT Comparison
Compare AMPH & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- PCT
- Stock Information
- Founded
- AMPH 1996
- PCT 2015
- Country
- AMPH United States
- PCT United States
- Employees
- AMPH N/A
- PCT N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- PCT Environmental Services
- Sector
- AMPH Health Care
- PCT Utilities
- Exchange
- AMPH Nasdaq
- PCT Nasdaq
- Market Cap
- AMPH 2.5B
- PCT 2.4B
- IPO Year
- AMPH 2014
- PCT N/A
- Fundamental
- Price
- AMPH $44.55
- PCT $11.69
- Analyst Decision
- AMPH Buy
- PCT Buy
- Analyst Count
- AMPH 4
- PCT 5
- Target Price
- AMPH $63.00
- PCT $10.60
- AVG Volume (30 Days)
- AMPH 404.9K
- PCT 3.0M
- Earning Date
- AMPH 11-06-2024
- PCT 11-15-2024
- Dividend Yield
- AMPH N/A
- PCT N/A
- EPS Growth
- AMPH 17.38
- PCT N/A
- EPS
- AMPH 3.01
- PCT N/A
- Revenue
- AMPH $723,549,000.00
- PCT N/A
- Revenue This Year
- AMPH $17.23
- PCT N/A
- Revenue Next Year
- AMPH $10.25
- PCT $517.44
- P/E Ratio
- AMPH $14.78
- PCT N/A
- Revenue Growth
- AMPH 20.33
- PCT N/A
- 52 Week Low
- AMPH $36.56
- PCT $2.39
- 52 Week High
- AMPH $65.92
- PCT $15.58
- Technical
- Relative Strength Index (RSI)
- AMPH 38.65
- PCT 50.18
- Support Level
- AMPH $43.09
- PCT $10.84
- Resistance Level
- AMPH $49.53
- PCT $12.55
- Average True Range (ATR)
- AMPH 1.76
- PCT 0.94
- MACD
- AMPH -0.62
- PCT -0.25
- Stochastic Oscillator
- AMPH 13.43
- PCT 24.57
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About PCT PureCycle Technologies Inc. Common stock
PureCycle Technologies Inc holds a license to commercialize the only patented solvent-based purification recycling technology, developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene (PP) into a virgin-like resin. The proprietary process removes color, odor, and other contaminants from recycled feedstock resulting in virgin-like polypropylene suitable for any PP market.